Pfizer Proposes Criteria To Allow Free Phytosterol CHD Reduction Claim

FDA should allow CHD reduction claims for nonesterified phytosterol supplements to that disperse efficiently from tablet form and help block cholesterol uptake, Pfizer argues in comments to the agency.